Holen Sie sich die Stockscreener-App
113.02
0.43%
0.48
Handel nachbörslich:
113.02
Schlusskurs vom Vortag:
$112.54
Offen:
$112.7
24-Stunden-Volumen:
1.86M
Relative Volume:
1.30
Marktkapitalisierung:
$22.50B
Einnahmen:
$7.60B
Nettoeinkommen (Verlust:
$1.08B
KGV:
46.90
EPS:
2.41
Netto-Cashflow:
$1.26B
1W Leistung:
+3.25%
1M Leistung:
+6.31%
6M Leistung:
-5.96%
1J Leistung:
+1.21%
1-Tages-Spanne:
$112.64
$114.72
1-Wochen-Bereich:
$108.25
$114.72
52-Wochen-Spanne:
$101.47
$133.90
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Firmenname
Zimmer Biomet Holdings Inc
Sektor
Branche
Telefon
(574) 267-6131
Adresse
345 EAST MAIN STREET, WARSAW, IN
Vergleichen Sie ZBH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| ZBH | 113.02 | 22.50B | 7.60B | 1.08B | 1.26B | 2.41 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-10 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-07-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-21 | Hochstufung | Argus | Hold → Buy |
| 2024-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Eingeleitet | ROTH MKM | Neutral |
| 2023-08-28 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-05-03 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-03-29 | Eingeleitet | UBS | Sell |
| 2023-03-10 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Underweight |
| 2022-10-12 | Eingeleitet | Jefferies | Underperform |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-04-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-02 | Fortgesetzt | BofA Securities | Underperform |
| 2022-03-02 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-02-08 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Bestätigt | Citigroup | Buy |
| 2022-02-08 | Bestätigt | Deutsche Bank | Hold |
| 2022-02-08 | Bestätigt | JMP Securities | Mkt Outperform |
| 2022-02-08 | Bestätigt | JP Morgan | Neutral |
| 2022-02-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Bestätigt | Stifel | Buy |
| 2022-02-08 | Bestätigt | Truist | Buy |
| 2022-02-08 | Bestätigt | UBS | Neutral |
| 2022-02-08 | Bestätigt | Wells Fargo | Underweight |
| 2022-02-02 | Herabstufung | UBS | Buy → Neutral |
| 2022-01-19 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Herabstufung | Needham | Strong Buy → Buy |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-11-23 | Herabstufung | Argus | Buy → Hold |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-09 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Bestätigt | Needham | Strong Buy |
| 2020-10-20 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-08-05 | Bestätigt | Needham | Strong Buy |
| 2020-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Bestätigt | Needham | Strong Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-09-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Hochstufung | Argus | Hold → Buy |
| 2019-07-30 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Hochstufung | Needham | Buy → Strong Buy |
Alle ansehen
Zimmer Biomet Holdings Inc Aktie (ZBH) Neueste Nachrichten
Zimmer Biomet's Leading Knee Revision System Gains CE Mark for European Expansion | ZBH Stock News - StockTitan
Corbyn Investment Management Inc. MD Grows Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Equity Investment Corp Invests $70.10 Million in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Thrivent Financial for Lutherans Trims Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
ING Groep NV Sells 90,246 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
UBS: Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Is A Bottom-Ranked Quant Stock - Yahoo Finance
Sumitomo Mitsui Trust Group Inc. Has $52.03 Million Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Receives $123.22 Consensus Target Price from Analysts - MarketBeat
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Sivik Global Healthcare LLC Makes New $4.32 Million Investment in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet's SWOT analysis: stock outlook amid ERP challenges, growth plans - Investing.com Australia
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Position Lessened by Assetmark Inc. - MarketBeat
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Zimmer Biomet Welcomes Arnold Schwarzenegger as Chief Movement Officer - MultiVu
Arnold Schwarzenegger Joins Zimmer Biomet as Chief Movement Officer in Landmark Partnership | ZBH Stock News - StockTitan
Principal Financial Group Inc. Sells 26,515 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. Appoints Arnold Schwarzenegger as Chief Movement Officer - Marketscreener.com
Victory Capital Management Inc. Reduces Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Janney Montgomery Scott LLC Buys 16,663 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Announces Leadership Transition - GuruFocus.com
Versor Investments LP Raises Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
ZBH Stock to Gain Support From Market Share Gains Amid Macro Issues - Yahoo Finance
Knee Replacement Market Is Booming Worldwide 2024-2031 | Zimmer - openPR
River Global Investors LLP Acquires 5,030 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Costello Asset Management INC - MarketBeat
Robeco Institutional Asset Management B.V. Sells 125,363 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
M&G Plc Acquires 21,251 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Lifeward Announces Appointment of Robert J. Marshall to Its Board of Directors - The Manila Times
Leeward Investments LLC MA Decreases Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet to Present at Jefferies London Healthcare Conference – Company Announcement - Financial Times
Shareholders Can Be Confident That Zimmer Biomet Holdings' (NYSE:ZBH) Earnings Are High Quality - Simply Wall St
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Position Boosted by National Pension Service - MarketBeat
Stephens Inc. AR Makes New $638,000 Investment in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings Inc. stock rises Wednesday, still underperforms market - MarketWatch
Zimmer Biomet Holdings Inc. stock rises Tuesday, still underperforms market - MarketWatch
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Bought by Heritage Investors Management Corp - MarketBeat
Zimmer Biomet falls on potential revenue hit from software issue - MSN
Royal Bank of Canada Issues Positive Forecast for Zimmer Biomet (NYSE:ZBH) Stock Price - MarketBeat
NeuroOne agree $3m partnership with Zimmer Biomet - Medical Device Network
Zimmer licenses NeuroOne brain ablation system - Yahoo Finance
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by US Bancorp DE - MarketBeat
Zimmer Biomet Holdings, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2015; Provides Earnings Guidance for the First Quarter and Full Year of Fiscal 2016 - Marketscreener.com
Roth Capital Decreases Earnings Estimates for Zimmer Biomet - MarketBeat
Zimmer Biomet Holdings (NYSE:ZBH) Expands with NeuroOne Alliance and Z1 Hip System Launch - Yahoo Finance
Van ECK Associates Corp Boosts Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet reports increased net sales in third-quarter 2024 financial results - Healio
Results: Zimmer Biomet Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Simply Wall St
Zimmer Biomet Holdings Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Zimmer Biomet net sales surge 4% to USD 1.824B in Q3 2024 - Medical Buyer
Finanzdaten der Zimmer Biomet Holdings Inc-Aktie (ZBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):